Identifying novel therapeutic agents using xenograft models of pediatric cancer

Medicine and Dentistry

• Combination Therapy 75%
• Xenograft 50%
• Childhood Cancer 50%
• Cytotoxic Agent 50%
• Therapeutic Procedure 50%
• Patient 50%
• Metastatic Carcinoma 25%
• Solid Malignant Neoplasm 25%
• Morbidity 25%
• Radiation Therapy 25%
• Toxicity 25%
• Surgery 25%
• Sequela 25%
• Cognitive Defect 25%
• Therapeutic Agent 25%
• Event Free Survival 25%
• Tissues 25%
• Experience 25%
• Inpatient 25%
• Spine 25%
• Childhood 25%
• Pediatric Cancer 25%
• Pediatrics 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Childhood Cancer 50%
• Cytotoxic Agent 50%
• Metastasis 25%
• Solid Malignant Neoplasm 25%
• Toxicity 25%
• Morbidity 25%
• Mouse Model 25%
• Cognitive Defect 25%
• Genetically Engineered Mouse Strain 25%
• Event Free Survival 25%